Intra-cellular Therapies, Inc. (ITCI) Tops Q2 EPS by 8c
Get Alerts ITCI Hot Sheet
Join SI Premium – FREE
Intra-cellular Therapies, Inc. (NASDAQ: ITCI) reported Q2 EPS of ($0.15), $0.08 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $319.2 thousand versus the consensus estimate of $410 thousand.
For earnings history and earnings-related data on Intra-cellular Therapies, Inc. (ITCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
- California Water Service (CWT) Tops Q1 EPS by 111c
- Equinor ASA (EQNR) Tops Q1 EPS by 22c, misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!